EGRP News Flash - February 2, 2010

NIH Announces Program Announcements for Small Business Innovation Research and Small Business Technology Grant Applications

The National Institutes of Health (NIH) recently released two Program Announcements (PAs) for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grant applications. The SBIR and STTR Programs are NCI's engine of innovation for developing and commercializing novel technologies and products to prevent, diagnose, and treat cancer. NCI's SBIR and STTR programs focus on research, development and delivery and are critical to achieving the institute's goals.

The research topics shown in the SBIR and STTR PAs represent program areas that may be of interest to applicant small business concerns in the development of projects that have potential for commercialization. NCI's SBIR and STTR Programs offer funding in nanotechnology, anti-cancer agents, biomarkers, proteomics, diagnostics, imaging technologies, pharmacodynamics, and many more areas of interest to the NCI. Small business concerns are encouraged to submit SBIR/STTR grant applications in these areas.

The SBIR and STTR topics of interest to the Epidemiology and Genetics Research Program (EGRP) include the following:

  • Developing tools for assessment of exposures and biomarkers, including:
    • Methods for measuring biomarkers of human exposure or susceptibility, and of nutritional status, and methods for monitoring changes in biomarkers for use in cancer epidemiologic studies;
    • New or improved devices for quantitative measurement of human exposure to environmental carcinogens for epidemiologic studies; and
    • Methods to evaluate potential cancer clusters for epidemiologic studies.
  • Developing tools for cancer epidemiology studies, including:
    • Tools to model cancer risks from environmental and occupational agents;
    • Software for electronic capture of risk factor data for cancer epidemiologic studies;
    • Consumer-friendly risk prediction models from epidemiologic data;
    • Software for tracking biological specimens for cancer epidemiologic studies;
    • Software for electronic identification, screening, and recruitment of participants, especially minorities, into epidemiologic studies;
    • Web-based data collection or applicable bioinformatics tools for cancer epidemiology;
    • Software or methods for rapid case ascertainment of cancers;
    • Geographic information systems with special visualization techniques for the simultaneous assessment of environmental exposures and health outcomes;
    • Tools using publicly available data to identify population-based controls for epidemiologic studies;
    • Software for analysis of DNA methylation biomarkers for early detection of prostate or breast cancers with use of specimens from biorepositories;
    • MicroRNA Profiling in epidemiologic studies; and
    • Detection of mitochondrial DNA alterations for cancer epidemiologic studies.

The opening date for these PAs is March 5, 2010 and the receipt dates are April 5, August 5, and December 5. The PAs expire on January 8, 2011.

For general questions about cancer epidemiology topics, contact EGRP's Mukesh Verma, Ph.D., Chief, Methods and Technologies Branch.

More information about the SBIR and STTR ProgramsExternal Web Site Policy.

Access the NIH Guide for Grants and Contracts:

  • PA-10-050External Web Site Policy: PHS 2010-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
  • PA-10-051External Web Site Policy: PHS 2010-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42])

Return to Top